A panel of ten ovarian cancer cell lines was stimulated with IGF-1 (Fig. 3A) or HRG (Fig. 3B) and proliferation was assessed via Cell Titer-Glo® Luminescent Cell Viability assay after 72 hours. The gene discussed is IGF1; the disease is ovarian carcinoma.